APA (7th ed.) Citation

K, M., R, B., C, K., Z, A., R, D., BC, P., & M, S. (2016). Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: Reply from the authors. The British journal of dermatology, 174(2), 463. https://doi.org/10.1111/bjd.14279

Chicago Style (17th ed.) Citation

K, Matter-Walstra, Braun R, Kolb C, Ademi Z, Dummer R, Pestalozzi BC, and Schwenkglenks M. "Treatment Specific Utility-weightings Are Needed for Cost-utility Analysis in Metastatic Melanoma: Reply from the Authors." The British Journal of Dermatology 174, no. 2 (2016): 463. https://doi.org/10.1111/bjd.14279.

MLA (9th ed.) Citation

K, Matter-Walstra, et al. "Treatment Specific Utility-weightings Are Needed for Cost-utility Analysis in Metastatic Melanoma: Reply from the Authors." The British Journal of Dermatology, vol. 174, no. 2, 2016, p. 463, https://doi.org/10.1111/bjd.14279.